vimarsana.com

Latest Breaking News On - Chris railey - Page 8 : vimarsana.com

Bicara Therapeutics Presents New Data from Ongoing Phase 1/1b Trial of Lead First-in-Class Bifunctional Program, BCA101, at the European Society for Medical Oncology (ESMO) Congress 2022

Stage one efficacy threshold achieved in dose expansion in patients with squamous cell carcinoma of the head and neck Webinar to review data to be held Monday, September 12th at 10:30 a.m. ET, featuring

France generalKostenloser wertpapierhandelSarah mccabeChris raileyLiviu niculescuGlennj hannaStern investor relations incDana farber cancer instituteEuropean society for medical oncologyPrincipal investigator glennEuropean societyMedical oncologyRare headNeck cancersPrincipal investigatorChief medical officer

Oak Hill Bio to Participate in Citi 17th Annual BioPharma Conference

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesUnited kingdomHill bioJosh distlerChris raileyTakeda pharmaceutical company limitedAnnual biopharma conferenceOak hillOak hill bioBusiness wire

Bicara Therapeutics to Present Clinical Data from Lead Precision Tumor Modulator Program, BCA101, at ESMO Congress 2022

Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to elicit a potent and durable immune response in the tumor microenvironment, today announced that

France generalKostenloser wertpapierhandelSarah mccabeChris raileyGlennj hannaStern investor relations incEuropean society for medical oncologyBicara therapeuticsEuropean societyMedical oncologyParis expo porte de versaillesMini oralInvestor relationsBridge communications

Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a. | June 28, 2022

United statesDanny rischinJulie seidelJohn leeLaurence reidBen panizzaChris raileyDivision of cancer medicineExchange commissionStern ir incNeck cancer centreChief development officerAmerican speech language hearing associationSpeech intelligibility indexCancer medicineMedical oncology

Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference

03.06.2022 - BOSTON, June 03, 2022 (GLOBE NEWSWIRE) - Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that .

Julie seidelChris raileyStern investor relations incAbout decibelDecibel therapeuticsInvestor relations

vimarsana © 2020. All Rights Reserved.